KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 7,460.00
-220.00 (-2.86%)
At close: Nov 13, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 81.36 billion as of November 13, 2026. It is the 28,260th most valuable company in the world and the 1,349th biggest in South Korea. Its market cap has decreased by 45.11% in one year.
Market Cap
81.36B
Enterprise Value
86.91B
Revenue
93.94B
Global Rank
Country Rank
#1,349 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 81.36B, a decrease of -55.73%. That is a compound annual growth rate of -12.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 81.36B | -42.62% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 96.66B |
| DongKoo Bio & Pharma | 91.81B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 88.83B |
| Samik Pharmaceutical Company LTD. | 83.86B |
| Cosmax Nbt | 80.27B |
| Pharos iBio | 78.84B |
| H.PIO | 78.46B |
| Sam-A Pharm. | 78.37B |